Skip to main content
Equibles
MRNA logo

MRNA · Moderna, Inc. · Metrics

Track MRNA — free

Use MRNA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MRNA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$228.38 +1.49 (+0.66%)
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$90.58B
Shares
399.24M
Volume · Oct 20 4.4M Avg daily vol (3M) 19.1M

MRNA metrics

91 of 116 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$226.89
Market cap
$90.58B

Price action

20 metrics
Price change (1W)
+6.2%
Price change (30D)
+31.2%
Price change (3M)
+281.4%
Price change (6M)
+315.6%
Price change (YTD)
+669.4%
Price change (1Y)
+772.3%
Trailing year
Price change (5Y)
-32.0%
52-week high
$236.50
52-week low
$22.36
Change from 52-week high
-4.1%
Change from 52-week low
+914.7%
Annualized volatility
194.1%
Annualized volatility (3M)
362.1%
Beta
2.2
RSI (14D)
64.3
Price vs SMA 50
+43.3%
Price vs SMA 200
+189.5%
Avg volume (3M)
19.10M
Relative volume
1.0
Average dollar volume
$3.04B

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
399.24M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
38.6×
reciprocal yield 2.6%
EV / EBITDA
—
EV / EBIT
—
P / sales
39.1×
reciprocal yield 2.6%
P / book
12.9
reciprocal yield 7.8%
FCF yield
-1.4%
TTM · current market cap
Buyback yield
0.0%
P / FCF
—
P / operating cash flow
—
Earnings yield
-3.6%

Historical valuation

8 metrics
P / E historical average (3Y)
11.1×
reciprocal yield 9.0%
P / E historical average (5Y)
11.1×
reciprocal yield 9.0%
EV / revenue historical average (3Y)
5.2×
reciprocal yield 19.1%
EV / revenue historical average (5Y)
5.6×
reciprocal yield 17.9%
EV / EBIT historical average (3Y)
25.8×
reciprocal yield 3.9%
EV / EBIT historical average (5Y)
25.8×
reciprocal yield 3.9%
EV / EBITDA historical average (3Y)
21.9×
reciprocal yield 4.6%
EV / EBITDA historical average (5Y)
21.9×
reciprocal yield 4.6%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-06
Last earnings
2026-07-31

Profitability

9 metrics
Gross margin
23.4%
Operating margin
-149.0%
Trailing 12 months
Net margin
-141.4%
Gross profit (TTM)
$521.00M
Operating profit (TTM)
−$3.32B
Net income (TTM)
−$3.15B
Trailing 12 months
Diluted EPS (TTM)
$-7.98
FCF margin
-55.8%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$5.68
Gross profit per diluted share (TTM)
$1.35
Operating profit per diluted share (TTM)
$-8.41
EBITDA per diluted share (TTM)
$-7.83
Net income per diluted share (TTM)
$-7.99
Operating cash flow per diluted share (TTM)
$-2.72
Free cash flow per diluted share (TTM)
$-3.15
Capital expenditures per diluted share (TTM)
$0.43
R&D per diluted share (TTM)
$7.31
Stock compensation per diluted share (TTM)
$1.17
Book value per share
$21.95

Growth

11 metrics
Revenue growth YoY
+2.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$2.23B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.6%
Year over year · more shares
Revenue CAGR (3Y)
-53.4%
Revenue CAGR (5Y)
+19.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-46.6%
Return on assets
-28.7%
Debt / equity
0.1
Current ratio
2.3
EBITDA (TTM)
−$3.09B
Free cash flow (TTM)
−$1.24B
Quick ratio
2.2
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$1.13B
Latest balance sheet
Cash & equivalents
$1.72B
Total assets
$10.96B
Total debt
$597.00M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$1.07B
Capital expenditures (TTM)
$171.00M
R&D (TTM)
$2.88B
SG&A (TTM)
—
Stock compensation (TTM)
$462.00M
R&D / revenue
129.1%
Stock compensation / revenue
20.7%

Ownership (13F)

3 metrics
13F filers
805
13F filer change QoQ
+61
Institutional ownership
90.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
20.0%

Short interest

3 metrics
Short interest
7.7%
Latest settlement · 1.8 days to cover
Days to cover
1.8d
Short-squeeze score
66 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$62.59M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1682852 CUSIP 60770K107 13F (30d) 162 filings 140 filers Visit website Investor relations